Beam Therapeutics Inc.
USD28.96
-2.18 (-7.00%)
CEO
John Evans
IPO Date
2020-02-06
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$30.34
Prev. Close
$31.14
Day Low
$28.80
Day High
$30.48
52W Low
$15.60
52W High
$36.44
Market Cap
$2.98B
Volume
1.72M
| 6,700 |
| $24.58 |
| 6 Apr 2026 | Cavanagh Bethany J | SVP, Finance and Treasurer | S-Sale | Disposed | 3,242 | $24.58 |
| 6 Apr 2026 | Bellon Christine | Chief Legal Officer | S-Sale | Disposed | 5,956 | $24.58 |
| 6 Apr 2026 | Ciaramella Giuseppe | President | S-Sale | Disposed | 11,810 | $24.58 |
| 2 Apr 2026 | Bellon Christine | Chief Legal Officer | A-Award | Acquired | 20,000 | $0.00 |
| 2 Apr 2026 | Cavanagh Bethany J | SVP, Finance and Treasurer | A-Award | Acquired | 20,000 | $0.00 |
| 2 Apr 2026 | Simon Amy | Chief Medical Officer | A-Award | Acquired | 31,750 | $0.00 |
| 2 Apr 2026 | Emany Sravan Kumar | Chief Financial Officer | A-Award | Acquired | 31,750 | $0.00 |
| 2 Apr 2026 | Ciaramella Giuseppe | President | A-Award | Acquired | 40,000 | $0.00 |